Your browser doesn't support javascript.
loading
Policies for biosimilar uptake in Europe: An overview.
Moorkens, Evelien; Vulto, Arnold G; Huys, Isabelle; Dylst, Pieter; Godman, Brian; Keuerleber, Simon; Claus, Barbara; Dimitrova, Maria; Petrova, Guenka; Sovic-Brkicic, Ljiljana; Slabý, Juraj; Sebesta, Robin; Laius, Ott; Karr, Allan; Beck, Morgane; Martikainen, Jaana E; Selke, Gisbert W; Spillane, Susan; McCullagh, Laura; Trifirò, Gianluca; Vella Bonanno, Patricia; Mack, Asbjørn; Fogele, Antra; Viksna, Anita; Wladysiuk, Magdalena; Mota-Filipe, Helder; Meshkov, Dmitry; Kalaba, Marija; Mencej Bedrac, Simona; Fürst, Jurij; Zara, Corrine; Skiöld, Peter; Magnússon, Einar; Simoens, Steven.
Afiliação
  • Moorkens E; KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
  • Vulto AG; Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Huys I; KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
  • Dylst P; KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
  • Godman B; Medicines for Europe, Brussels, Belgium.
  • Keuerleber S; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Claus B; Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
  • Dimitrova M; Main Association of Austrian Social Security Institutions, Vienna, Austria.
  • Petrova G; Faculty of pharmaceutical sciences, Ghent University, Ghent, Belgium.
  • Sovic-Brkicic L; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Slabý J; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Sebesta R; Croatian Health Insurance Fund, Zagreb, Croatia.
  • Laius O; State Institute for Drug Control, Prague, Czech Republic.
  • Karr A; State Institute for Drug Control, Brno, Czech Republic.
  • Beck M; State Agency of Medicines, Tartu, Estonia.
  • Martikainen JE; Department of Traumatology and Orthopedics, University of Tartu, Tartu, Estonia.
  • Selke GW; Karr Consultancy Ltd, Hertfordshire, United Kingdom.
  • Spillane S; OMEDIT Alsace, Agence Régionale de Santé du Grand Est, Strasbourg, France.
  • McCullagh L; Research Unit, Social Insurance Institution, Helsinki, Finland.
  • Trifirò G; Wissenschaftliches Institut der AOK (WIdO), Berlin, Germany.
  • Vella Bonanno P; Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland.
  • Mack A; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
  • Fogele A; Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland.
  • Viksna A; National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland.
  • Wladysiuk M; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
  • Mota-Filipe H; Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
  • Meshkov D; Division Pharmaceuticals, Norwegian Hospital Procurement Trust, Oslo, Norway.
  • Kalaba M; Department of Medicines and Medical Devices, The National Health Service, Riga, Latvia.
  • Mencej Bedrac S; Department of Medicines and Medical Devices, The National Health Service, Riga, Latvia.
  • Fürst J; HTA Consulting, Cracow, Poland.
  • Zara C; Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.
  • Skiöld P; Semashko National Research Institute for Public Health, Moscow, Russia.
  • Magnússon E; Primary healthcare center Zemun, Belgrade, Serbia.
  • Simoens S; Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, Ljubljana, Slovenia.
PLoS One ; 12(12): e0190147, 2017.
Article em En | MEDLINE | ID: mdl-29284064
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica